KTTAW (NASDAQ) is a cross-listing of KTTA (NASDAQ). Showing primary listing data.
KTTA
Pasithea Therapeutics Corp.
1W: -2.8%
1M: -0.2%
3M: -30.1%
YTD: -33.0%
1Y: -30.7%
3Y: -92.0%
$0.80
+0.01 (+1.91%)
After Hours: $0.76 (-0.04, -4.64%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.9M
52W Range0.281-3.79
Volume190,424
Avg Volume179,591
Beta0.20
Dividend—
Analyst Ratings
Company Info
CEOTiago Reis Marques
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-15
Websitepasithea.com
1111 Lincoln Road
Miami Beach, FL 33139
US
Miami Beach, FL 33139
US
702 514 4174
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Latest News
Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Dumesnil Simon | P-Purchase | 33,333 | $0.75 | 2025-11-28 |
| Leahy Emer | A-Award | 33,333 | $0.75 | 2025-11-28 |
| STEINMAN LAWRENCE | P-Purchase | 133,333 | $0.75 | 2025-11-28 |
| Schneiderman Daniel | A-Award | 26,667 | $0.75 | 2025-11-28 |
| Marques Tiago | P-Purchase | 33,333 | $0.75 | 2025-11-28 |